Literature DB >> 22226537

Three-year outcome of transvaginal mesh repair for the treatment of pelvic organ prolapse.

Cheng-Yu Long1, Chun-Shuo Hsu, Chin-Hu Wu, Cheng-Min Liu, Chiu-Lin Wang, Eing-Mei Tsai.   

Abstract

OBJECTIVE: To evaluate the clinical and urodynamic outcomes of transvaginal mesh repair (TVM) for the treatment of pelvic organ prolapse (POP). STUDY
DESIGN: One hundred and twenty-four women with POP stage II to IV were scheduled for a TVM procedure. Preoperative and postoperative assessments included pelvic examination, urodynamic testing, and a personal interview about urinary symptoms using a standard questionnaire.
RESULTS: We found a significant improvement at points Aa, Ba, C, Ap, and Bp (P<0.001) except for total vaginal length (P=0.08), and the overall success rate was 93.5% (116/124). Various urinary symptoms improved significantly following TVM (P<0.01). In addition, residual urine, functional urethral length, and the rate of detrusor overactivity, improved significantly after surgery (P<0.05). Apart from vaginal erosion (14/124; 11.3%), the rates of other surgical complications were acceptably low.
CONCLUSION: TVM is an effective procedure for the treatment of POP and urinary symptoms, this being possibly related to postoperative release of urethral obstruction. Vaginal erosion is less likely to occur beyond the learning curve. Crown Copyright Â
© 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22226537     DOI: 10.1016/j.ejogrb.2011.12.007

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

Review 1.  Challenges and future prospects for tissue engineering in female pelvic medicine and reconstructive surgery.

Authors:  Bertha Chen; Bhumy Dave
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

2.  Tension-free vaginal mesh for patients with pelvic organ prolapse: mid-term functional outcomes.

Authors:  Daisuke Obinata; Kenya Yamaguchi; Sho Hashimoto; Tsuyoshi Yoshizawa; Junichi Mochida; Satoru Takahashi
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

3.  Mesh complications and failure rates after transvaginal mesh repair compared with abdominal or laparoscopic sacrocolpopexy and to native tissue repair in treating apical prolapse.

Authors:  Vani Dandolu; Megumi Akiyama; Gayle Allenback; Prathamesh Pathak
Journal:  Int Urogynecol J       Date:  2016-08-25       Impact factor: 2.894

4.  Long-term outcomes of synthetic transobturator nonabsorbable anterior mesh versus anterior colporrhaphy in symptomatic, advanced pelvic organ prolapse surgery.

Authors:  Tsia-Shu Lo; Leng Boi Pue; Yiap Loong Tan; Pei-Ying Wu
Journal:  Int Urogynecol J       Date:  2013-08-14       Impact factor: 2.894

5.  Comparison of clinical outcomes using "elevate anterior" versus "Perigee" system devices for the treatment of pelvic organ prolapse.

Authors:  Cheng-Yu Long; Chiu-Lin Wang; Ming-Ping Wu; Chin-Hu Wu; Kun-Ling Lin; Cheng-Min Liu; Eing-Mei Tsai; Ching-Ju Shen
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

6.  Laparoscopic Organopexy with Non-mesh Genital (LONG) Suspension: A Novel Uterine Preservation Procedure for the Treatment of Apical Prolapse.

Authors:  Cheng-Yu Long; Chiu-Lin Wang; Chin-Ru Ker; Yung-Shun Juan; Eing-Mei Tsai; Kun-Ling Lin
Journal:  Sci Rep       Date:  2018-03-20       Impact factor: 4.379

7.  Comparison of UpholdTM Vaginal Mesh Procedure with Hysterectomy or Uterine Preservation for the Treatment of Pelvic Organ Prolapse.

Authors:  Chin-Ru Ker; Kun-Ling Lin; Zi-Xi Loo; Yung-Shun Juan; Cheng-Yu Long
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

8.  The clinical and urodynamic outcomes of single-incision mesh surgery using the Uphold system for the treatment of pelvic organ prolapse.

Authors:  Pei-Chi Wu; Chin-Hu Wu; Yiyin Liu; Zixi Loo; Kun-Ling Lin; Cheng-Yu Long
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.